Publications by authors named "L Celio"

Claim this Profile
H
HR20013, a fixed-dose intravenous combination of fosrolapitant and palonosetron, for the prevention of cisplatin-induced nausea and vomiting: putting the PROFIT trial into perspective.
Luigi Celio, Andrea Antonuzzo

Ann Palliat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-day vs single-day dexamethasone for the prophylaxis of chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.
Ronald Chow, Luigi Celio, James Im, Saverio Caini, Lawson Eng

Support Care Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on "Dexamethasone-sparing on days 2-4 with combined palonosteron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)".
Luigi Celio, Andrea Antonuzzo, Matti S Aapro

Br J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of nausea and its impact on health-related quality of life in cisplatin-treated patients receiving dexamethasone-sparing prophylaxis: an analysis of the LUNG-NEPA study.
Luigi Celio, Matti Aapro

Support Care Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.
J Herrstedt, R Clark-Snow, C H Ruhlmann, A Molassiotis, I Olver, L Celio

ESMO Open· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis